Cited by 34

The DOI matches its Crossref record.

Development of a Cell-Based, High-Throughput Screening Assay for Cholesterol Efflux Using a Fluorescent Mimic of Cholesterol

Zhang, Jun, Cai, Sutang, Peterson, Blake R., Kris-Etherton, Penny M., Heuvel, John P. Vanden·2011·ASSAY and Drug Development Technologies

Abstract

Reverse cholesterol transport is the process by which extrahepatic cells, including macrophage-derived foam cells in arterial atherosclerotic plaque, transport excessive cholesterol back to the liver for bile acid synthesis and excretion, thus lowering the peripheral lipid burden. Cholesterol efflux from peripheral cells is the first step in this process, and finding drugs and interventions that promote this event is an important endeavor. Radioisotope-labeled cholesterol traditionally has been employed in measuring efflux efficiency, but this reagent has limitations for high-throughput screening. We developed an alternative method to measure cholesterol efflux in macrophage-derived foam cells using a novel fluorescent cholesterol mimic comprising the Pennsylvania Green fluorophore, attached by a linker containing a glutamic acid residue, to a derivative of N-alkyl-3β-cholesterylamine. Compared with the traditional radioisotope-based assay, this fluorescence-based assay gave similar results in the presence of known modulators of cholesterol efflux, such as cyclic AMP, and different cholesterol acceptors. When the fluorescent probe was employed in a high-throughput screening format, a variety of chemicals and bioactive compounds with known and unknown effects on cholesterol efflux could be tested simultaneously by plate-reader in a short period of time. Treatment of THP-1-derived macrophages with inhibitors of the membrane transporter ATP-binding cassette A1, such as glyburide or a specific antibody, significantly reduced the export of this fluorescent compound, indicating that ATP-binding cassette A1 represents the primary mediator of its cellular efflux. This fluorescent mimic of cholesterol provides a safe, sensitive, and reproducible alternative to radioactive assays in efflux experiments and has great potential as a valuable tool when incorporated into a drug discovery program.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1089/adt.2010.0288

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 38

  1. 10.1016/j.pharmthera.2006.02.003 · DOI
  2. 10.1161/ATVBAHA.107.158998 · DOI
  3. 10.1016/j.cmet.2008.03.001 · DOI · Paper page
  4. 10.1021/ol052655g · DOI
  5. 10.1021/jf051505h · DOI
  6. 10.1177/108705719900400206 · DOI · Paper page
  7. 10.3181/00379727-196-43185 · DOI
  8. 10.3109/09687689509038505 · DOI
  9. 10.1021/bi0008534 · DOI
  10. 10.1016/S0022-2275(20)34891-4 · DOI
  11. 10.1074/jbc.275.17.12769 · DOI
  12. 10.1002/cbf.1048 · DOI
  13. 10.1002/jcb.22667 · DOI
  14. 10.1074/jbc.M003434200 · DOI
  15. 10.1161/CIRCULATIONAHA.105.593855 · DOI
  16. 10.1152/ajpheart.01075.2008 · DOI
  17. 10.1016/j.bbalip.2006.09.018 · DOI
  18. 10.1161/01.ATV.0000235697.35431.05 · DOI
  19. 10.1017/BJN20061866 · DOI
  20. 10.1093/jn/134.11.2991 · DOI
  21. 10.1016/j.bbrc.2005.08.204 · DOI
  22. 10.1093/ajcn/85.2.385 · DOI
  23. 10.1161/ATVBAHA.109.187252 · DOI
  24. 10.1161/ATVBAHA.109.198036 · DOI
  25. 10.1074/jbc.271.48.30647 · DOI
  26. 10.1016/S1388-1981(99)00041-4 · DOI
  27. 10.1016/S0022-2275(20)34893-8 · DOI
  28. 10.1074/jbc.M003337200 · DOI
  29. 10.1161/01.RES.0000250171.54048.5c · DOI · Paper page
  30. 10.1111/j.1365-2796.2007.01898.x · DOI · Paper page
  31. 10.1021/bi0004192 · DOI
  32. 10.1194/jlr.M300358-JLR200 · DOI
  33. 10.1194/jlr.M600145-JLR200 · DOI
  34. 10.1016/j.biopha.2006.07.090 · DOI
  35. 10.1111/j.1471-4159.2008.05433.x · DOI
  36. 10.1083/jcb.200601030 · DOI
  37. 10.1016/j.bbrc.2008.09.009 · DOI
  38. 10.1042/bj2690807 · DOI

Cited by

Sorted by citations

Metadata

Authors
Zhang, J., Cai, S., Peterson, B. R., Kris-Etherton, P. M., & Heuvel, J. P. V.
Affiliations
  • The Pennsylvania State University
  • The University of Kansas
Venue
ASSAY and Drug Development Technologies
Published
2011-04
Volume
9
Issue
2
Pages
136-146
ISSN
  • 1540-658X
  • 1557-8127
Cited by
34
References
0
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review